CD163 and stroke disorder: BML‐111 significantly increased the percent of Iba1+/CD163+ cells compared to the vehicle, indicating that BML‐111 increases the M2, anti‐inflammatory phenotype in microglia and macrophages 1 week post‐stroke (p < .001; Figure 3b,c).